Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.
about
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.Monitoring and managing antibiotic resistance in refugee children.Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates.Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016.Tackling the Antibiotic Resistance Caused by Class A -Lactamases through the Use of -Lactamase Inhibitory ProteinAppropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms
P2860
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.
@en
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.
@nl
type
label
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.
@en
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.
@nl
prefLabel
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.
@en
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.
@nl
P2860
P1433
P1476
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy.
@en
P2093
Darren Wong
P2860
P2888
P304
P356
10.1007/S40265-017-0725-1
P577
2017-04-01T00:00:00Z